Phospho-PI3 Kinase p85 (Tyr458)/p55 (Tyr199) (Clone: 1A11) rabbit mAb, Clone: [PI3KY458-1A11], Unconjugated, Rabbit, Monoclonal

Artikelnummer: ABI-12-4057
Artikelname: Phospho-PI3 Kinase p85 (Tyr458)/p55 (Tyr199) (Clone: 1A11) rabbit mAb, Clone: [PI3KY458-1A11], Unconjugated, Rabbit, Monoclonal
Artikelnummer: ABI-12-4057
Hersteller Artikelnummer: 12-4057
Alternativnummer: ABI-12-4057-200UL
Hersteller: Abeomics
Wirt: Rabbit
Kategorie: Antikörper
Applikation: FACS
Spezies Reaktivität: Human, Mouse
Immunogen: A synthetic phospho-peptide corresponding to residues surrounding Tyr458 of human phospho PI3K p85
Konjugation: Unconjugated
Alternative Synonym: Phosphatidylinositol 3-kinase regulatory subunit alpha, PIK3R1, GRB1, Phosphatidylinositol 3-kinase regulatory subunit beta, PIK3R2, Phosphatidylinositol 3-kinase regulatory subunit gamma, PIK3R3, p55PIK
Phosphoinositidine 3-kinase (PI3K) targets phosphoinositide lipids for phosphorylation at the D-3 position to serve as a second messenger molecule to activate signaling pathways in response to extracellular stimuli. Akt/protein kinase B (PKB) is a major downstream target of PI3K. The multiple forms of PI3K have different specificities and different affinities for various phosphatidylinositol forms. The PH domains of downstream proteins in these pathways bind to these secondary messengers, causing altered cellular distribution and subsequent kinase activation. The PI3K/Akt pathway is altered in a large proportion of human cancers, as this pathway regulates cellular survival, cell cycle progression, and cell growth.
Klonalität: Monoclonal
Klon-Bezeichnung: [PI3KY458-1A11]
Formulierung: Purified
Application Verdünnung: 1µg/mL - 0.001µg/mL. It is recommended that the reagent be titrated for optimal performance for each application. See product image legends for additional information.(0.5mg/ml)